Hinova Pharmaceuticals Inc
SSE:688302
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hinova Pharmaceuticals Inc's stock price target?
Not Available
Hinova Pharmaceuticals Inc doesn't have any price targets made by Wall Street professionals.
What is Hinova Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
733%
For the last 5 years the compound annual growth rate for Hinova Pharmaceuticals Inc's revenue is -39%. The projected CAGR for the next 3 years is 733%.